Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Inventory (2018 - 2025)

TELA Bio has reported Inventory over the past 8 years, most recently at $11.0 million for Q4 2025.

  • Quarterly results put Inventory at $11.0 million for Q4 2025, down 13.81% from a year ago — trailing twelve months through Dec 2025 was $11.0 million (down 13.81% YoY), and the annual figure for FY2025 was $11.0 million, down 13.81%.
  • Inventory for Q4 2025 was $11.0 million at TELA Bio, down from $11.6 million in the prior quarter.
  • Over the last five years, Inventory for TELA hit a ceiling of $15.1 million in Q1 2023 and a floor of $4.5 million in Q2 2021.
  • Median Inventory over the past 5 years was $12.0 million (2022), compared with a mean of $11.3 million.
  • Biggest five-year swings in Inventory: soared 128.54% in 2022 and later decreased 15.01% in 2025.
  • TELA Bio's Inventory stood at $7.7 million in 2021, then skyrocketed by 53.98% to $11.8 million in 2022, then increased by 11.62% to $13.2 million in 2023, then decreased by 2.89% to $12.8 million in 2024, then decreased by 13.81% to $11.0 million in 2025.
  • The last three reported values for Inventory were $11.0 million (Q4 2025), $11.6 million (Q3 2025), and $11.4 million (Q2 2025) per Business Quant data.